AskBio Inc.

About AskBio Inc.

AskBio Inc. is a biotechnology company developing adeno-associated virus (AAV)-based gene therapies for rare genetic diseases, neuromuscular and central nervous system disorders. Founded in 2001 by Jude Samulski, the company operates a proprietary AAV technology platform, scalable manufacturing facilities, and a pipeline spanning pre-clinical to late-stage clinical programs. AskBio was acquired by Bayer in 2020 and continues to operate as its wholly owned subsidiary, advancing investigational treatments for conditions such as Pompe disease, Huntington’s disease and heart failure.